|
Cost-minimization analysis and (last row) percentage variation of economical parameters in r-FSH vs. HP-uFSH treatment |
||||||||
| Mean FSH IU/cycle (95%CI) |
Mean n. of vials/cycle (95%CI) (A) |
Cost per vial (€) (B) |
Mean cost/cycle (€) (C) = (A) × (B) |
Total n. of vials (95%CI) (D) = (A) × 130 |
N. of deliveries (95%CI) (E) |
Total n. of vials/delivery (F) = (D)/(E) |
Cost per delivery (€) (B) × (F) |
|
|
|
||||||||
| HP-uFSH |
844 (741–947) |
11.3 (9.9–12.6) |
15.55 |
175.71 |
1,469 (1,287–1,638) |
13 (6–20) |
113 (214–82) |
1,757.15 |
| r-FSH |
668 (575–761) |
8.9 (7.7–10.1) |
23.40 |
208.26 |
1,157 (1,001–1,313) |
17 (9–25) |
68 (111–53) |
1,591.20 |
| % |
-20.8 |
-21.2 |
+50.5 |
+18.5 |
-21.2 |
+30.8 |
-39.8 |
-9.4 |
Revelli et al. Reproductive Biology and Endocrinology 2006 4:38 doi:10.1186/1477-7827-4-38 |
||||||||